Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adverse Effects of ATG/ALG Therapy in Aplastic Anemia
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Summary
This prospective, single-center, observational cohort study aims to systematically observe and describe the clinical characteristics of adverse reactions in patients with aplastic anemia undergoing ATG (Anti-Thymocyte Globulin) /ALG (Anti-Lymphocyte Globulin) treatment, providing a data foundation for the development of relevant management strategies. This study plans to enroll 200 aplastic anemia patients undergoing ATG/ALG treatment
Official title: A Study on the Dynamics and Grading Criteria Construction of Adverse Reactions to ATG/ALG Therapy in Aplastic Anemia
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-02-23
Completion Date
2027-12-31
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
ATG/ALG
Participants will receive ATG/ALG according to standard dosing protocols as per clinical guidelines. During treatment, we will monitor and document any adverse reactions, including their type, severity, duration, and any necessary interventions or changes in treatment plan.
Locations (1)
Regenerative Medicine Center and Red Blood Cell Disorders Center
Tianjin, China